3 CYCLES OF CHEMOTHERAPY FOLLOWED BY PRIMARY CYTOREDUCTIVE SURGERY FOR UNRESECTABLE OVARIAN-CANCER

被引:1
|
作者
GUIDOZZI, F
SONNENDECKER, EWW
机构
关键词
D O I
10.1016/0090-8258(91)90043-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Definitive primary cytoreductive surgery was achieved at second laparotomy after three cycles of combination chemotherapy (cisplatin and cyclophosphamide) in three patients who presented with unresectable disease at our Ovarian Tumor Unit. The ovarian cancer was inoperable at the first laparotomy and no surgical procedure was performed other than biopsy of malignant tumor to confirm the diagnosis. Following interventional surgical cytoreduction the patients were given a further six courses of combination chemotherapy and then maintained for a further six cycles on oral chlorambucil. Two patients are disease free at 17 and 21 months, respectively, while the other patient has cytological evidence of malignancy but no other clinically detectable tumor deposits at 27 months. © 1991.
引用
收藏
页码:313 / 316
页数:4
相关论文
共 50 条
  • [21] Evaluation of Optimal Number of Neoadjuvant Chemotherapy Cycles and Cytoreductive Surgery in Women with Ovarian Cancer
    Hassani, Shahrzad Sheikh
    Moradpanah, Somayeh
    Akhavan, Setare
    Mousavi, Azamsadat
    Zamani, Narges
    Rezayof, Elahe
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 22 (01)
  • [22] Evaluation of Optimal Number of Neoadjuvant Chemotherapy Cycles and Cytoreductive Surgery in Women with Ovarian Cancer
    Shahrzad Sheikh Hassani
    Somayeh Moradpanah
    Setare Akhavan
    Azamsadat Mousavi
    Narges Zamani
    Elahe Rezayof
    Indian Journal of Gynecologic Oncology, 2024, 22
  • [23] NEOADJUVANT (CYTOREDUCTIVE) CHEMOTHERAPY COMBINED WITH INTERVENTION DEBULKING SURGERY IN ADVANCED, UNRESECTED EPITHELIAL OVARIAN-CANCER
    LAWTON, FG
    REDMAN, CWE
    LUESLEY, DM
    CHAN, KK
    BLACKLEDGE, G
    OBSTETRICS AND GYNECOLOGY, 1989, 73 (01): : 61 - 65
  • [24] RESULTS OF A PHASE I TRIAL OF HYPERTHERMIC INTRAPERITONEAL CISPLATIN AFTER NEOADJUVANT CHEMOTHERAPY AND CYTOREDUCTIVE SURGERY AND FOLLOWED BY BEVACIZUMAB IN INITIALLY UNRESECTABLE OVARIAN CANCER
    Gouy, S.
    Ferron, G.
    Glehen, O.
    Le Deley, M. C.
    Marchal, F.
    Pomel, C.
    Quenet, F.
    Bereder, J. M.
    Kochler, L.
    Morice, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [25] THE RARE INDICATION FOR SPLENECTOMY AS PART OF CYTOREDUCTIVE SURGERY IN OVARIAN-CANCER
    DEPPE, G
    ZBELLA, EA
    SKOGERSON, K
    DUMITRU, I
    GYNECOLOGIC ONCOLOGY, 1983, 16 (02) : 282 - 287
  • [26] SURVIVAL OF PATIENTS FOLLOWING SECONDARY CYTOREDUCTIVE SURGERY IN OVARIAN-CANCER
    BEREK, JS
    HACKER, NF
    LAGASSE, LD
    NIEBERG, RK
    ELASHOFF, RM
    OBSTETRICS AND GYNECOLOGY, 1983, 61 (02): : 189 - 193
  • [27] Cost effectiveness of neoadjuvant chemotherapy followed by interval cytoreductive surgery versus primary cytoreductive surgery for patients with advanced stage ovarian cancer during the initial treatment phase
    Tran, Arthur-Quan
    Erim, Daniel O.
    Sullivan, Stephanie A.
    Cole, Ashley L.
    Barber, Emma L.
    Kim, Kenneth H.
    Gehrig, Paola A.
    Wheeler, Stephanie B.
    GYNECOLOGIC ONCOLOGY, 2018, 148 (02) : 329 - 335
  • [28] LOCALIZED OVARIAN-CANCER - SURGERY PLUS CHEMOTHERAPY
    FIORENTINO, MV
    NICOLETTO, O
    DEBESI, P
    STEFANI, G
    TREDESE, F
    VINANTE, O
    FORNASIERO, A
    CECCHETTO, A
    MAGGINO, T
    MARCHESONI, D
    NARDELLI, G
    ONNIS, A
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (11): : 1365 - 1370
  • [29] Primary cytoreductive surgery versus neoadjuvant chemotherapy followed by surgery in patients with advanced primary epithelial ovarian cancer in low resources setting: a randomized clinical trial
    Abou-Taleb, Hisham
    Hussien, Ali
    Ismail, Alaa
    Abdel-Kawi, Af
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A193 - A194
  • [30] RADICAL SURGERY IN PATIENTS REFERRED WITH A DIAGNOSIS OF UNRESECTABLE OVARIAN-CANCER
    SONNENDECKER, EWW
    BEALE, PG
    SOUTH AFRICAN MEDICAL JOURNAL, 1987, 71 (10): : 621 - 625